Invenomic Capital Management’s Intel INTC Stock Holding History

Invenomic Capital Management’s Portfolio INTC Stock Details INTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-413,151	Closed	-$8.28M	–	183
2024 Q4	$8.28M	Buy	413,151 +183,216	+80%	+$4.13M	0.39%	86
2024 Q3	$5.39M	Buy	+229,935	New	+$5.74M	0.3%	95
2023 Q2	–	Sell	-231,829	Closed	-$7.57M	–	146
2023 Q1	$7.57M	Sell	231,829 -257,120	-53%	-$7.28M	0.43%	73
2022 Q4	$12.9M	Buy	488,949 +216,804	+80%	+$6.02M	0.88%	36
2022 Q3	$7.01M	Buy	272,145 +118,626	+77%	+$4.04M	0.6%	56
2022 Q2	$5.74M	Buy	+153,519	New	+$6.64M	0.41%	71
2021 Q3	–	Sell	-4,900	Closed	-$275K	–	133
2021 Q2	$275K	Buy	+4,900	New	+$288K	0.07%	107
2021 Q1	–	Sell	-38,381	Closed	-$1.91M	–	137
2020 Q4	$1.91M	Buy	+38,381	New	+$1.87M	0.49%	40
2020 Q2	–	Sell	-3,224	Closed	-$175K	–	168
2020 Q1	$175K	Buy	+3,224	New	+$191K	0.14%	121

Other funds holding INTC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invenomic Capital Management's INTC Position: Q1 2025 in Review

Invenomic Capital Management sold out of Intel (INTC) in Q1 2025, closing a stake of 413,151 shares — an estimated $8.28M sold.

Invenomic Capital Management first reported a position in INTC in Q1 2020 and held it in 9 quarters. The position peaked at $12.9M in Q4 2022. 2,077 funds tracked by Wall St. Rank hold INTC as of Q1 2025.

Invenomic Capital Management reported no remaining Intel position as of Q1 2025 after selling out during the quarter.
Invenomic Capital Management sold 413,151 Intel shares in Q1 2025, an estimated $8.28M.
Invenomic Capital Management first reported a position in Intel in Q1 2020 and held it in 9 quarters.
Invenomic Capital Management's Intel position peaked at $12.9M in Q4 2022.
2,077 funds tracked by Wall St. Rank held Intel as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.